DMK Pharmaceuticals Corp Stock Price Today NASDAQ DMK Live Ticker

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company’s lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder.

Top institutional shareholders include BlackRock Inc. (1.42%), Geode Capital Management LLC (0.68%), Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Robert O Hopkins and Ronald B Moss. Shares of Adamis Pharmaceuticals reverse split on Monday, May 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

There’s a shortage of U.S. EpiPens and other allergic reaction treatments

Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction. The industry https://1investing.in/ with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Allergy group says U.S. has shortage of EpiPens, other allergic reaction treatments

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Shares of Adamis Pharmaceuticals oversold stocks today Corp. shot up 58% toward a six-month high in premarket trade Monday, after the maker Symjepi, a competitor to Mylan N.V.’s EpiPen, announced a distribution and commercialization agreement… Adamis Pharmaceuticals Corp. shares surged in the extended session Wednesday after the biotech company said its partner Sandoz Inc. launched an alternative to epinephrine auto-injectors like Mylan NV’s EpiPen.

© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

Adamis Pharma stock jumps after FDA agrees to review injectable opioid-overdose treatment

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.

• Click the link below and we’ll send you MarketBeat’s list of seven stocks and why their long-term outlooks are very promising.
• In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals.
• Shares of Adamis Pharmaceuticals Corp. shot up 58% toward a six-month high in premarket trade Monday, after the maker Symjepi, a competitor to Mylan N.V.’s EpiPen, announced a distribution and commercialization agreement…
• The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
• This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system.

Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy. /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws… Adamis Pharmaceuticals’ stock is owned by a variety of retail and institutional investors.

DMK Pharmaceuticals Corp Analysis

Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Adamis Pharmaceuticals Corp. shares soared 53% to a one-year high Thursday after the company’s allergic reaction treatment, intended as a rival to Mylan’s EpiPen , was approved by the Food and Drug Administration. Shares of the U.S.-listed Teva Pharmaceutical Industries Ltd. surged 6.2% in extremely heavy Thursday afternoon trade after the company’s generic version of the EpiPen allergic reaction treatment was by the Food and Drug …

Allergy advocacy group Food Allergy Research and Education says that the U.S. is facing a growing national shortage of EpiPens and other allergic reaction treatments called epinephrine auto-injectors. Shares of Adamis Pharmceuticals Corp. fell 52% in trading on Monday after the Food and Drug Administration rejected its application for Zimhi, a naloxone product aimed at treating opioid overdose. The Barchart Technical Opinion widget shows you today’s overally Barchart Opinion with general information on how to interpret the short and longer term signals.

Trading Services

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more. March S&P 500 futures (ESH23) are trending up +0.07% this morning after three major U.S. benchmark indices ended the regular session higher as investors digested an early round of U.S. economic data and… Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”)… The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Click the link below and we’ll send you MarketBeat’s list of seven stocks and why their long-term outlooks are very promising.

An industry with a larger percentage of Zacks Rank #1′s and #2′s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4′s and #5′s. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. Upgrade to MarketBeat All Access to add more stocks to your watchlist.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat’s FREE daily newsletter. Visit a quote page and your recently viewed tickers will be displayed here.

The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. Shares of Adamis Pharmaceuticals Corp. soared 20.4% on massive volume toward an eight-month high in premarket trading Monday, after the biopharmaceutical company said Zimhi, it’s high-dose naloxone injection for the treat… At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year.

These returns cover a period from January 1, 1988 through July 31, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month.